Health Reform Bill Downsizing Would Send Pharma Back To Bargaining Table
This article was originally published in The Tan Sheet
Executive Summary
The biopharmaceutical industry will look to renegotiate its financial contribution to health reform if congressional Democratic leaders determine that a much more modest bill is the best way forward following the loss of their 60-seat super-majority in the Senate